ζ-Stat (trisodium)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


ζ-Stat (trisodium)
Description:
ζ-Stat trisodium (NSC37044 trisodium) is a specific and atypical PKC-ζ inhibitor, with an IC50 of 5 μM. ζ-Stat trisodium can reduce melanoma cell lines proliferation and induce apoptosis, and has antitumor activity in vitro[1][2].Product Name Alternative:
NSC37044 (trisodium)UNSPSC:
12352005Target:
Apoptosis; PKCType:
Reference compoundRelated Pathways:
Apoptosis; Epigenetics; TGF-beta/SmadApplications:
Cancer-Kinase/proteaseField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/ζ-stat-trisodium.htmlPurity:
97.0Solubility:
H2O : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)Smiles:
O=S(C1=C2C(O)=CC(S(=O)(O[Na])=O)=CC2=CC(S(=O)(O[Na])=O)=C1)(O[Na])=OMolecular Formula:
C10H5Na3O10S3Molecular Weight:
450.31References & Citations:
[1]Ratnayake WS, et, al. Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors. Cell Adh Migr. 2018; 12 (5) :447-463.|[2]Islam SMA, et, al. Atypical Protein Kinase-C inhibitors exhibit a synergistic effect in facilitating DNA damaging effect of 5-fluorouracil in colorectal cancer cells. Biomed Pharmacother. 2020 Jan; 121:109665.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
PKCζCAS Number:
[31894-34-5]
